Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06830109

Nasal Obstruction With Oxymetazoline and Corticosteroids

Led by Washington University School of Medicine · Updated on 2025-09-11

80

Participants Needed

1

Research Sites

115 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to examine the efficacy and safety of commination oxymetazoline/intranasal steroids for long-term management of chronic nasal obstruction that is recalcitrant to the current standard of care. The investigators hypothesize that combination treatment with oxymetazoline and intranasal corticosteroid spray will provide a larger reduction in nasal obstruction than intranasal corticosteroid alone for patients suffering from chronic nasal obstruction, and there will not be occurrences of rhinitis medicamentosa.

CONDITIONS

Official Title

Nasal Obstruction With Oxymetazoline and Corticosteroids

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female aged 18 years or older
  • History of nasal obstruction
  • Failed prior daily use of topical steroids for at least 1 month
  • Able to read, write, and understand English
  • Do not want surgery or are poor surgical candidates due to other medical conditions
  • Prior use of oxymetazoline or other nasal decongestants allowed if stopped at least 4 weeks before enrollment
  • Willing to stop using other nasal sprays except saline and to avoid oral decongestants during the study
Not Eligible

You will not qualify if you...

  • History of sinonasal mass or tumor
  • History of nasal polyps
  • Known chronic sinusitis
  • Allergy to oxymetazoline
  • Medical contraindication to oxymetazoline use such as pulmonary hypertension

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Washington University

St Louis, Missouri, United States, 63110

Actively Recruiting

Loading map...

Research Team

N

Nyssa Farrell, MD

CONTACT

S

Sara Kukuljan

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Nasal Obstruction With Oxymetazoline and Corticosteroids | DecenTrialz